Skip to content
1887

Microbial Genomics logo Microbial Genomics

Volume 12, Issue 2

Genomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru Open Access

Abstract

To determine changes in the pneumococcal serotypes, sequence types (STs), clonal complexes (CCs) and the frequency of antimicrobial resistance genes after the introduction of pneumococcal conjugate vaccines (PCVs) in Lima, Peru. Retrospective multicentre study analysing whole-genome sequencing (WGS) data from three passive surveillance studies of invasive pneumococcal disease (IPD) in paediatric patients in Lima (2006–2020). Pneumococcal typing and antimicrobial resistance were analysed using genomic tools. CCs were identified with eBURST and phylogenetic results were visualized using PHYLOViZ. 262 pneumococcal isolates were analysed (104 from IPD1, 70 from IPD2 and 88 from IPD3), 55.3% from children under 2 years old, 53.1% from patients with pneumonia and 28.5% with meningitis. After the introduction of PCVs, vaccine serotypes decreased, while serotype 19A and non-vaccine serotypes increased. The predominant STs were ST156 in IPD1 (=25) and in IPD2 (=7); and ST320 (=38) and ST230 (=15) in IPD3. Sixteen CC were identified, the most frequent were CC1421 (=58) and CC156 (=36). The overall penicillin non-susceptibility (NS) increased from 21.8% in IPD1 to 28.6% in IPD3, ceftriaxone-NS increased from 10% to 13.1% and macrolide-NS from 24.8% to 85.7% respectively. Resistance markers for macrolides, tetracycline and cotrimoxazole increased post-PCV13. WGS predicted antimicrobial resistance with high concordance, though some discrepancies were noted with phenotypic testing methods. Important changes in the distribution of serotype and ST, especially among vaccine serotypes, have been observed. These findings highlight the importance of monitoring vaccine effectiveness and tracking changes in bacterial populations to guide future vaccine implementation.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antimicrobial resistance , clonal complexes , phylogenetic , pneumococcal conjugate vaccine , sequence types and whole-genome sequencing
Funding
This study was supported by the:
  • Pfizer (Award ID#76571479)
    • Principal Award Recipient: TheresaJ. Ochoa
© 2026 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001621
2026-02-03
2026-02-09

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/12/2/mgen001621.html?itemId=/content/journal/mgen/10.1099/mgen.0.001621&mimeType=html&fmt=ahah

References

  1. Narciso AR, Dookie R, Nannapaneni P, Normark S, Henriques-Normark B. Streptococcus pneumoniae epidemiology, pathogenesis and control. Nat Rev Microbiol 2025; 23:256–271 [View Article] [PubMed]
     [Google Scholar]
  2. GBD 2016 Lower Respiratory Infections Collaborators Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018; 18:1191–1210 [View Article]
     [Google Scholar]
  3. Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet Lond Engl 2022; 399:629–655 [View Article]
     [Google Scholar]
  4. Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MPE et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 2015; 15:535–543 [View Article] [PubMed]
     [Google Scholar]
  5. Dion SB, Major M, Gabriela Grajales A, Nepal RM, Cane A et al. Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines. Vaccine 2021; 39:3007–3017 [View Article] [PubMed]
     [Google Scholar]
  6. Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK et al. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect 2016; 22:60 [View Article] [PubMed]
     [Google Scholar]
  7. Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR et al. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 2011; 203:1360–1368 [View Article] [PubMed]
     [Google Scholar]
  8. Hanquet G, Krizova P, Dalby T, Ladhani SN, Nuorti JP et al. Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe. Emerg Infect Dis 2022; 28:137–138 [View Article] [PubMed]
     [Google Scholar]
  9. Ochoa TJ, Egoavil M, Castillo ME, Reyes I, Chaparro E et al. Invasive pneumococcal diseases among hospitalized children in Lima, Peru. Rev Panam Salud Publica 2010; 28:121–127 [View Article]
     [Google Scholar]
  10. Luna-Muschi A, Castillo-Tokumori F, Deza MP, Mercado EH, Egoavil M et al. Invasive pneumococcal disease in hospitalised children from Lima, Peru before and after introduction of the 7-valent conjugated vaccine. Epidemiol Infect 2019; 147:e91 [View Article] [PubMed]
     [Google Scholar]
  11. Ochoa TJ, Del Águila O, Reyes I, Chaparro E, Castillo ME et al. Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru. J Infect Public Health 2024; 17:44–50 [View Article] [PubMed]
     [Google Scholar]
  12. Hung HCH, Kumar N, Dyster V, Yeats C, Metcalf B et al. GPS Pipeline: portable, scalable genomic pipeline for Streptococcus pneumoniae surveillance from Global Pneumococcal Sequencing Project. Nat Commun 2025; 16:8345 [View Article] [PubMed]
     [Google Scholar]
  13. Lees JA, Harris SR, Tonkin-Hill G, Gladstone RA, Lo SW et al. Fast and flexible bacterial genomic epidemiology with PopPUNK. Genome Res 2019; 29:304–316 [View Article]
     [Google Scholar]
  14. Hawkins PA, Akpaka PE, Nurse-Lucas M, Gladstone R, Bentley SD et al. Antimicrobial resistance determinants and susceptibility profiles of pneumococcal isolates recovered in Trinidad and Tobago. J Glob Antimicrob Resist 2017; 11:148–151 [View Article] [PubMed]
     [Google Scholar]
  15. Gagetti P, Lo SW, Hawkins PA, Gladstone RA, Regueira M et al. Population genetic structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in children in Argentina. Microbial Genomics 2021; 7:000636 [View Article]
     [Google Scholar]
  16. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007; 3:e168 [View Article] [PubMed]
     [Google Scholar]
  17. Ansaldi F, Canepa P, de Florentiis D, Bandettini R, Durando P et al. Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine. Clin Vaccine Immunol 2011; 18:343–345 [View Article] [PubMed]
     [Google Scholar]
  18. Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L et al. Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol 2014; 6:1589–1602 [View Article]
     [Google Scholar]
  19. Mott MP, Caierão J, Cunha GR, Del Maschi MM, Pizzutti K et al. Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil. Epidemiol Infect 2019; 147:e93 [View Article] [PubMed]
     [Google Scholar]
  20. Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL et al. Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis 2025; 25:445–456 [View Article] [PubMed]
     [Google Scholar]
  21. Corcoran M, Mereckiene J, Cotter S, Murchan S, Lo SW et al. Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures. Vaccine 2021; 39:5064–5073 [View Article] [PubMed]
     [Google Scholar]
  22. Camacho Moreno G, Imbachi LF, Leal AL, Moreno VM, Patiño JA et al. Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Hum Vaccines Immunother 2020; 16:2300–2306 [View Article]
     [Google Scholar]
  23. Potin M, Fica A, Wilhem J, Cerda J, Contreras L et al. Statement of the Advisory Immunization Committee of the Chilean Society of Infectious Diseases on the emergence of serotype 19A pneumococcal infection and the use of pneumococcal conjugated vaccine in Chilean children. Rev Chilena Infectol 2016; 33:304–306 [View Article] [PubMed]
     [Google Scholar]
  24. Puzia W, Gawor J, Gromadka R, Żuchniewicz K, Wróbel-Pawelczyk I et al. Highly resistant serotype 19A Streptococcus pneumoniae of the GPSC1/CC320 clone from invasive infections in Poland prior to antipneumococcal vaccination of children. Infect Dis Ther 2023; 12:2017–2037 [View Article] [PubMed]
     [Google Scholar]
  25. Gagetti P, Menocal A, Faccone D, Fossati S, Napoli D et al. 1429. Emergence of multidrug-resistant serotype 24 among children under 2 years old with invasive pneumococcal disease after the introduction of PCV13 in Argentina. Open Forum Infect Dis 2018; 5:S441–S441 [View Article]
     [Google Scholar]
  26. Gomez CA, Gonzales BE, Hernández RA, Campos F, Chaparro E et al. Clinical and microbiological characteristics of pediatric patients hospitalized for pneumococcal pneumonia before and after the introduction of pneumococcal conjugate vaccines. Rev Peru Med Exp Salud Publica 2025; 42:63–69 [View Article] [PubMed]
     [Google Scholar]
  27. Rodriguez-Ruiz JP, Xavier BB, Stöhr W, van Heirstraeten L, Lammens C et al. High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland. BMC Microbiol 2024; 24:146 [View Article] [PubMed]
     [Google Scholar]
  28. Gonzales BE, Mercado EH, Pinedo-Bardales M, Hinostroza N, Campos F et al. Increase of macrolide-resistance in Streptococcus pneumoniae strains after the introduction of the 13-valent pneumococcal conjugate vaccine in Lima, Peru. Front Cell Infect Microbiol 2022; 12:866186 [View Article] [PubMed]
     [Google Scholar]
  29. Schroeder MR, Lohsen S, Chancey ST, Stephens DS. High-level macrolide resistance due to the Mega element [mef(E)/mel] in Streptococcus pneumoniae. Front Microbiol 2019; 10:868 [View Article]
     [Google Scholar]
  30. Del Grosso M, Northwood JGE, Farrell DJ, Pantosti A. The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271. Antimicrob Agents Chemother 2007; 51:4184–4186 [View Article] [PubMed]
     [Google Scholar]
  31. Ecker L, Olarte L, Vilchez G, Ochoa TJ, Amemiya I et al. Physicians’ responsibility for antibiotic use in infants from periurban Lima, Peru. Rev Panam Salud Publica 2011; 30:574–579 [PubMed]
     [Google Scholar]
  32. Metcalf BJ, Chochua S, Gertz RE Jr, Li Z, Walker H et al. Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States. Clin Microbiol Infect 2016; 22:1002 [View Article] [PubMed]
     [Google Scholar]
  33. Ramos V, Duarte C, Díaz A, Moreno J. Mobile genetic elements associated with erythromycin-resistant isolates of Streptococcus pneumoniae in Colombia. Biomedica 2014; 34 Suppl 1:209–216 [View Article] [PubMed]
     [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001621
Loading
Genomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru
M Gen 12, 001621 (2026); https://doi.org/10.1099/mgen.0.001621
/content/journal/mgen/10.1099/mgen.0.001621
/content/journal/mgen/10.1099/mgen.0.001621
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Supplementary material 2

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error